DCs interacting with Hyp-PDT-treated cancer cells exhibit a fully mature immunogenic phenotype functionally characterized by significant secretion of immunostimulatory factors like IL-1β, IL-6, nitric oxide, and the absence of the immunosuppressive cytokine, IL-10 (50). The gene discussed is IL6; the disease is cancer.